Rhumbline Advisers Aurinia Pharmaceuticals Inc. Transaction History

Rhumbline Advisers

$121 Billion
Q3 2025

A detailed history of Rhumbline Advisers transactions in Aurinia Pharmaceuticals Inc. stock. As of the latest transaction made, Rhumbline Advisers holds 171,139 shares of AUPH stock, worth $2.63 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

171,139

Previous 176,766 3.18%

Holding current value

$2.63 Million

Previous $1.5 Million 26.32%

% of portfolio

0.0%

Previous 0.0%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Nov 06, 2025	SELL	$7.47 - $13.14 $42,033 - $73,938	-5,627 Reduced 3.18%	171,139 $1.89 Million
Q2 2025 Aug 12, 2025	SELL	$7.2 - $8.64 $122,176 - $146,612	-16,969 Reduced 8.76%	176,766 $1.5 Million
Q1 2025 Apr 08, 2025	BUY	$7.55 - $8.77 $936 - $1,087	124 Added 0.06%	193,735 $1.61 Million
Q4 2024 May 29, 2025	SELL	$6.75 - $10.44 $837 - $1,294	-124 Reduced 0.06%	193,611 $1.74 Million
Q4 2024 Jan 30, 2025	SELL	$6.75 - $10.44 $1,215 - $1,879	-180 Reduced 0.09%	193,611 $1.74 Million

Q3 2024 Nov 12, 2024	SELL	$5.32 - $7.33 $76,991 - $106,079	-14,472 Reduced 6.95%	193,791 $1.42 Million
Q2 2024 Aug 01, 2024	BUY	$4.81 - $5.78 $117,224 - $140,864	24,371 Added 13.25%	208,263 $1.19 Million
Q1 2024 May 09, 2024	BUY	$4.93 - $9.31 $12,561 - $23,721	2,548 Added 1.41%	183,892 $921,000
Q4 2023 Feb 08, 2024	BUY	$7.13 - $9.49 $4,734 - $6,301	664 Added 0.37%	181,344 $1.63 Million
Q3 2023 Nov 09, 2023	BUY	$7.77 - $12.27 $12,074 - $19,067	1,554 Added 0.87%	180,680 $1.4 Million
Q2 2023 Aug 08, 2023	BUY	$8.96 - $11.69 $50,391 - $65,744	5,624 Added 3.24%	179,126 $1.73 Million
Q1 2023 May 11, 2023	BUY	$5.94 - $11.27 $41,277 - $78,315	6,949 Added 4.17%	173,502 $1.9 Million
Q4 2022 Feb 14, 2023	BUY	$4.11 - $8.14 $10,981 - $21,750	2,672 Added 1.63%	166,553 $720,000
Q3 2022 Nov 10, 2022	BUY	$6.66 - $12.39 $79,953 - $148,741	12,005 Added 7.9%	163,881 $1.23 Million
Q2 2022 Aug 11, 2022	BUY	$8.95 - $12.8 $1.36 Million - $1.94 Million	151,876 New	151,876 $1.53 Million

Others Institutions Holding AUPH

# of Institutions

268

Shares Held

69.3M

Call Options Held

984K

Put Options Held

574K

View Full List

About Aurinia Pharmaceuticals Inc.

Ticker AUPH
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 141,892,000
Market Cap $2.18B
Description
Aurinia Pharmaceuticals Inc., a commercial-stage biopharmaceutical company, focuses on developing and commercializing therapies to treat various diseases with unmet medical need in the United States and internationally. The company offers LUPKYNIS for the treatment of adult patients with active lupus nephritis. It has a collaboration and license...

More about AUPH

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Rhumbline Advisers, based on Form 13F filings with the SEC.

News

Stay updated on Rhumbline Advisers with notifications on news.

Account

Rhumbline Advisers Aurinia Pharmaceuticals Inc. Transaction History